WorksheetsAspiris MDP Post Quiz (NORTH + EAST)
Total questions: 27
Worksheet time: 15mins
Enter your employee ID
Select your Designation
SSO
AM
RSM
DGM
HO
_______________ % of drug having particle size between 1-5 microns.
Aerosol
Fine particle fraction
Fine particle mass
Emitted dose
Select right preferred controller & reliever for Mild intermittent Asthma (Step 1)
As needed Low dose ICS + Formoterol
Low dose ICS+LABA
Med dose ICS+LABA
LTRA
What is the duration of action of Glycopyrronium 50 mcg ( LAMA ) bronchodilator?
12 hrs
20 hrs
24 hrs
6 hrs
Our Capsule container is dessicant free & offers ease of handling
True
False
Muscarinic antagonist like Glycopyrronium is selective to _____ receptor
M1
M2
M3
M1 & M3
Select all benefits of SMART therapy ( Multiple options can be correct)
A patient can use a single inhaler as controller and reliever
Cost effective therapy
Better reduction in risk of exacerbation
Patient can use all SKUs as SMART
Budesonide does not show a dose response relationship
True
False
If patients come with severe persistent Asthma then which strength of Combihlae FB Dr will prescribe
Combihale 200 MDI 1 puff BID
Combihale 200 MDI 2 puff BID
Combihale 400 MDI 2 puff BID
Combihale 400 1 puff BID
Combihale FB Forte can be promoted in which indication (Select 2 options)
Asthma COPD Overalp
Asthma
COPD patients with eosinophils <100 cells per micro liter of blood
COPD patients with eosinophilia (>300 cells per micro liter of blood)
In MDI (Combihale FB 200) our FPF is ______ for individual components as compared to Cipla MDI
Less
High
Comparable
Equal
In Combihale FF, Oral bioavailability of Fluticasone is ______% due to which it offers less systemic side effects
>20
11 %
<1
35
Fluticasone in Combihale FF has a less receptor binding affinity, making it more potent ICS
True
False
Dosage of Combihale FF 500 DPI caps is
1 cap BID
2 cap BID
1 cap OD
2 Cap OD
FF combination offers low rates of exacerbation as compared to other ICS + LABA . As per meta analysis the pooled incidence of OCS excaerbation was ___%
5
2.1
3
7
Select the right composition of GFF combination -
Formoterol 6 mcg + Glycopyrrolate 12.5 mcg
Formoterol 12 mcg + Glycopyrrolate 12.5 mcg
Formoterol 12 mcg + Glycopyrrolate 25 mcg
Formoterol 4.8 mcg + Glycopyrrolate 9 mcg
Onset of action of Glycopyrrolate is _____ minutes
3
7
5
4
LABA + LAMA combination offers complete coverage of the Lungs because
Muscarinic antagonist like Glycopyrronium targets M3 receptors whose density in more on larger airways
Muscarinic antagonist like Glycopyrronium targets M3 receptors whose density in more on smaller airways
Beta 2 agonist like Formoterol targets beta 2 receptor whose density is more in smaller airways
Beta 2 agonist like Formoterol targets beta 2 receptor whose density is more in larger airways
Select right dosage of Formoterol 12 mcg + Glycopyrrolate 25 mcg DPI Cap
1 cap OD
2 cap OD
2 cap BID
1 Cap BID
Both Indacaterol + Glycopyrronium & Formoterol + Glycopyrrolate can be used as starting therapy in GOLD group
D
B
C
B & D
Select the right composition of Indacaterol + Glycopyrronium combination
Indacaterol 110 mcg + Glycopyrronium 50 mcg
Indacaterol 50 mcg + Glycopyrronium 110 mcg
Indacaterol 200 mcg + Glycopyrronium 50 mcg
None of above
As per GLYCO 2 study: Which BID dose of Glycopyrrolate is the optimal dose? (Select 2 options)
12.5 mcg BID
25 mcg BID
50 mcg BID
9 mcg BID
Usually maximum recommended dose of Fluticasone propionate in a day is ____ mcg
800 mcg
1200
1600
1000
Prana patient support includes which services -
Diet counseling
Yoga exercise
Mental health session
Physitherapist counseline
Inhalation device training
As per meta analysis Formoterol + Glycopyrronium is having comparable efficacy as other LABA + LAMA based on which parameteres
SGRQ score
Trough FEV1
Peak FEV1
All of above
COPD patient already taking LAMA drug from last 8 months . Came to Pulmonologist for follow up with major complain of dyspnoea. What should be the drug of choice for this patient
LABA + LAMA
LABA + LAMA + ICS
Add on Roflumilast
Add on Azithromycin
